HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Zhu Selected Research

erythrocyte membrane protein band 4.1-like 1

1/2022Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Zhu Research Topics

Disease

170Neoplasms (Cancer)
10/2022 - 08/2005
57Inflammation (Inflammations)
09/2022 - 01/2008
28Infections
01/2022 - 07/2009
25Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2022 - 01/2011
22Breast Neoplasms (Breast Cancer)
03/2022 - 01/2008
20Alzheimer Disease (Alzheimer's Disease)
11/2022 - 11/2010
18Neoplasm Metastasis (Metastasis)
03/2022 - 12/2006
18Traumatic Brain Injuries (Traumatic Brain Injury)
08/2018 - 01/2007
17Multiple Sclerosis
12/2022 - 01/2011
15Parkinson Disease (Parkinson's Disease)
01/2022 - 10/2012
15Atherosclerosis
01/2022 - 09/2012
14Colorectal Neoplasms (Colorectal Cancer)
09/2022 - 01/2013
14Obesity
05/2022 - 05/2014
14Carcinogenesis
04/2022 - 12/2012
13Pancreatitis
03/2022 - 03/2005
13Hypoxia (Hypoxemia)
01/2022 - 05/2011
13Stroke (Strokes)
01/2021 - 01/2011
12Fibrosis (Cirrhosis)
07/2022 - 03/2010
11Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 01/2015
11Insulin Resistance
01/2022 - 02/2013
11Stomach Neoplasms (Stomach Cancer)
12/2021 - 03/2012
9COVID-19
08/2022 - 01/2020
9Body Weight (Weight, Body)
05/2022 - 12/2014
9Peripheral Nervous System Diseases (PNS Diseases)
01/2022 - 01/2018
9Cognitive Dysfunction
01/2021 - 01/2016
9Wounds and Injuries (Trauma)
01/2021 - 03/2008
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 01/2015
8Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2011
8Brain Injuries (Brain Injury)
12/2020 - 01/2009
8Glioblastoma (Glioblastoma Multiforme)
01/2020 - 02/2011
7Neuroinflammatory Diseases
12/2022 - 10/2014
7Lung Neoplasms (Lung Cancer)
04/2022 - 09/2011
7Virus Diseases (Viral Diseases)
01/2022 - 10/2014
7Type 2 Diabetes Mellitus (MODY)
01/2022 - 10/2008
7Diabetes Mellitus
01/2022 - 01/2017
7Glioma (Gliomas)
10/2021 - 01/2013
7Epilepsy (Aura)
10/2021 - 08/2012
7Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2021 - 11/2011
7Ischemia
01/2021 - 08/2012
7Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
06/2020 - 01/2011
6Memory Disorders (Memory Loss)
11/2022 - 01/2018
6Pneumonia (Pneumonitis)
01/2022 - 02/2009
6Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 12/2011
6Demyelinating Diseases (Demyelinating Disease)
01/2021 - 01/2011
6Cicatrix (Scar)
08/2020 - 09/2011
5Brain Edema (Cerebral Edema)
05/2022 - 05/2012

Drug/Important Bio-Agent (IBA)

56Proteins (Proteins, Gene)FDA Link
03/2022 - 08/2005
39Pharmaceutical PreparationsIBA
03/2022 - 01/2013
34Biomarkers (Surrogate Marker)IBA
05/2022 - 03/2012
21MatrinesIBA
07/2022 - 01/2011
21LipidsIBA
06/2022 - 10/2008
21CytokinesIBA
05/2022 - 01/2007
21Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2008
18MicroRNAs (MicroRNA)IBA
02/2022 - 03/2012
17Biological ProductsIBA
01/2022 - 05/2011
16EnzymesIBA
03/2022 - 01/2009
16Messenger RNA (mRNA)IBA
02/2022 - 01/2008
13RNA (Ribonucleic Acid)IBA
05/2022 - 11/2018
13AntigensIBA
03/2022 - 08/2006
12MicellesIBA
01/2022 - 01/2013
10Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2007
10Insulin (Novolin)FDA Link
01/2022 - 02/2013
10NAD (NADH)IBA
01/2022 - 01/2009
10Quinolizidine AlkaloidsIBA
01/2022 - 01/2011
10Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2007
9DNA (Deoxyribonucleic Acid)IBA
10/2022 - 01/2013
9Small Interfering RNA (siRNA)IBA
03/2022 - 06/2012
9Oxygen (Dioxygen)IBA
01/2022 - 09/2014
9Amyloid (Amyloid Fibrils)IBA
01/2022 - 11/2010
9ZincIBA
12/2016 - 01/2007
8HydrogelsIBA
03/2022 - 09/2014
8Antiviral Agents (Antivirals)IBA
01/2022 - 09/2017
8Long Noncoding RNAIBA
01/2022 - 01/2016
8Interleukin-17 (Interleukin 17)IBA
01/2022 - 08/2012
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 12/2006
8Triglycerides (Triacylglycerol)IBA
05/2021 - 10/2008
7salicylhydroxamic acid (SHAM)IBA
05/2022 - 01/2007
7Therapeutic UsesIBA
03/2022 - 01/2011
7LigandsIBA
02/2022 - 12/2010
7Glutamine (L-Glutamine)FDA Link
02/2022 - 02/2011
7oxidized low density lipoproteinIBA
01/2022 - 01/2013
7Apolipoproteins E (ApoE)IBA
01/2022 - 09/2014
7Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 02/2006
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2007
7AntioxidantsIBA
08/2020 - 01/2009
6AntibodiesIBA
08/2022 - 08/2012
6Paclitaxel (Taxol)FDA LinkGeneric
08/2021 - 06/2012
6Indicators and Reagents (Reagents)IBA
01/2021 - 08/2005
6VaccinesIBA
01/2020 - 08/2006
6Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2019 - 04/2014
6Estrogens (Estrogen)FDA Link
01/2019 - 12/2012
6Peptides (Polypeptides)IBA
08/2018 - 01/2014
6NF-E2-Related Factor 2IBA
01/2014 - 01/2013

Therapy/Procedure

63Therapeutics
07/2022 - 03/2009
21Drug Therapy (Chemotherapy)
07/2022 - 10/2008
18Radiotherapy
01/2022 - 11/2013
9Immunotherapy
05/2022 - 01/2014
8Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 03/2005
7Photochemotherapy (Photodynamic Therapy)
01/2022 - 01/2016
6Aftercare (After-Treatment)
03/2021 - 12/2011